A study to assess trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors
Latest Information Update: 28 Oct 2020
At a glance
- Drugs Lenvatinib (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics
- 28 Oct 2020 New trial record